GlassScriptPhysician profile
Madison Gilmore
NPI 1326618398
$7,401.56
in general payments reported to CMS, 2019-2025
29 companies · $1,665 in 2025
The $1,665 reported for 2025 was more than what 91% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $48.40 · 2022: $1,748 · 2023: $2,049 · 2024: $1,891 · 2025: $1,665.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,142 · Education: $464.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,141.94 |
| Education | $463.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,110.31 | 2021-2025 | |
| Janssen Biotech, INC. | $939.90 | 2022-2025 | Tremfya |
| Sun Pharmaceutical Industries INC. | $656.16 | 2021-2025 | Ilumya, Absorica Ld, Winlevi |
| Dermavant Sciences, INC. | $458.03 | 2023-2024 | Vtama |
| Ucb, INC. | $409.20 | 2024-2025 | Bimzelx |
| Incyte Corporation | $374.34 | 2022-2025 | Opzelura |
| Genzyme Corporation | $359.30 | 2022-2023 | |
| Galderma Laboratories, L.P. | $329.25 | 2022-2025 | Aklief, Epsolay, Oracea |
| Lilly USA, LLC | $289.33 | 2023-2025 | Olumiant, Taltz, Ebglyss |
| Journey Medical Corporation | $249.98 | 2022 | |
| Janssen Scientific Affairs, LLC | $240.37 | 2022 | |
| Epi Health, LLC | $230.76 | 2022 | |
| Allergan, INC. | $224.90 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $205.87 | 2022-2025 | Dupixent, Libtayo |
| Biofrontera INC. | $197.58 | 2022-2025 | Ameluz, Xepi, Bf-Rhodoled |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Leo Pharma INC. | $196.26 | 2023-2025 | Adbry |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $193.77 | 2024-2025 | Cabtreo, Siliq, Jublia |
| Almirall LLC | $135.87 | 2022-2025 | Klisyri, Seysara |
| Pfizer INC. | $126.33 | 2023-2025 | |
| Novartis Pharmaceuticals Corporation | $126.18 | 2023-2025 | |
| Sanofi-Aventis U.S. LLC | $99.99 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $51.30 | 2024 | Spevigo |
| Arcutis Biotherapeutics, INC. | $47.01 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $39.76 | 2023 | Sotyktu |
| Takeda Pharmaceuticals U.S.A., INC. | $31.17 | 2025 | |
| Springworks Therapeutics, INC. | $25.10 | 2025 | Gomekli |
| Organon LLC | $24.29 | 2025 | Vtama |
| Nabriva Therapeutics, Plc | $21.49 | 2022 | |
| Mayne Pharma Commercial LLC | $7.76 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Madison Gilmore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.